Cargando…
S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS
Autores principales: | José Cuenca Zamora, Ernesto, Águila, Sonia, José Lis, María, Carmen Garcia Hernandez, Maria, Jose Fernández, María, Soledad Noya Pereira, María, Mora Castera, Elvira, Palomera Bernal, Luis, Alicia Senin Magan, Maria, Pérez López, Raúl, Encinas, Manuel Perez, Figueras, Anna Angona, Manuel Puerta, José, Vallansot, Rolando, Garcia, Venancio Conesa, Carlos Hernandez-Boluda, Juan, Mas, Ana Rosell, Cortés, Montserrat, Ortí, Guillermo, Xicoy Cirici, Blanca, Carreño Gomez-Tarragona, Gonzalo, Giraldo, Pilar, Lozano, Maria L, Gutierrez, Valentin Garcia, Ferrer-Marín, Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428472/ http://dx.doi.org/10.1097/01.HS9.0000967524.87606.24 |
Ejemplares similares
-
P680: PONATINIB 15 MG AS CONSOLIDATION PRIOR TO TREATMENT FREE REMISSION IN CHRONIC MYELOID LEUKEMIA
por: Garcia Gutierrez, Valentin, et al.
Publicado: (2023) -
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients
por: Hernández-Boluda, Juan Carlos, et al.
Publicado: (2018) -
Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis
por: Mosquera-Orgueira, Adrián, et al.
Publicado: (2022) -
PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
por: Torra, Silvia Marce, et al.
Publicado: (2023) -
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
por: Alvarez‐Larrán, Alberto, et al.
Publicado: (2022)